This report contains market size and forecasts of Neurodegenerative Diseases Therapeutics in Global, including the following market information:
Global Neurodegenerative Diseases Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neurodegenerative Diseases Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Multiple Sclerosis Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neurodegenerative Diseases Therapeutics include AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., Biogen Inc., F. Hoffmann La Roche Ltd., H Lundbeck AS, Mitsubishi Chemical Holdings Corp., Novartis AG and Sanofi and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurodegenerative Diseases Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurodegenerative Diseases Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neurodegenerative Diseases Therapeutics Market Segment Percentages, by Type, 2021 (%)
Multiple Sclerosis Therapeutics
Alzheimer's Disease Therapeutics
Parkinson's Disease Therapeutics
Parkinson's Disease Therapeutics
Others
Global Neurodegenerative Diseases Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neurodegenerative Diseases Therapeutics Market Segment Percentages, by Application, 2021 (%)
Child
Aldult
Global Neurodegenerative Diseases Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neurodegenerative Diseases Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurodegenerative Diseases Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neurodegenerative Diseases Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AB Science SA
AbbVie Inc.
Acadia Pharmaceuticals Inc.
Biogen Inc.
F. Hoffmann La Roche Ltd.
H Lundbeck AS
Mitsubishi Chemical Holdings Corp.
Novartis AG
Sanofi
Teva Pharmaceutical Industries Ltd